[1]
F. A. Al-Rawashde, “In silico Evaluation of the Antileukemia Activities of Thymoquinone by Targeting FLT3-ITD and BCR-ABL Signaling in Myeloid leukemia”, TJNPR, vol. 8, no. 6, pp. 7447–7451, Jun. 2024, doi: 10.26538/tjnpr/v8i6.17.